The warrant exercise proceeds extend the cash runway modestly but do not change the fundamental outlook. Monitor the next quarterly report for updated cash burn rate and pipeline progress.
Price Chart
Executive Summary
SELLAS Life Sciences disclosed it received approximately $28.7 million in warrant exercise proceeds during April and May 2026, and reported 196,632,574 shares outstanding as of June 2, 2026. The company had $107.1 million in cash as of March 31, 2026. This is a routine capital structure update with no material operational or financial results.
Key Facts
- As of March 31, 2026, SELLAS had $107.1 million in cash and cash equivalents.
- Received approximately $28.7 million in proceeds from common stock warrant exercises in April and May 2026.
- As of June 2, 2026, the company had 196,632,574 shares of common stock outstanding.
Financial Impact
Cash balance increased by ~$28.7M from warrant exercises, adding to the $107.1M reported at Q1 end.
Risk Factors
- Dilution from warrant exercises is already reflected in the share count; further warrant overhang may remain.
- No revenue or earnings data provided; cash runway and clinical trial milestones remain key catalysts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-069251 |
| Document: 0001104659-26-069251-index-headers.html | 0001104659-26-069251 |
| Document: 0001104659-26-069251-index.html | 0001104659-26-069251 |
| Document: 0001104659-26-069251.txt | 0001104659-26-069251 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | Press Release | $11.61 | awaiting T+60 | — | $11.53 (−0.65%) |
Jun 2, 2026 21w ago | 8-K | $8.33 $13.73 | ▲ +64.83% | ▲ +63.71% | $11.53 (+38.48%) |
May 12, 2026 23w ago | 8-K | $6.53 $12.01 | ▲ +83.92% | ▲ +79.48% | $11.53 (+76.65%) |
Apr 23, 2026 26w ago | DEFA14A | $4.46 $12.90 | ▲ +189.24% | ▲ +184.16% | $11.53 (+158.63%) |
Mar 19, 2026 31w ago | Press Release | $4.76 $7.83 | ▲ +64.50% | ▲ +50.08% | $11.53 (+142.33%) |
Mar 17, 2026 31w ago | Press Release | $4.95 $7.75 | ▲ +56.57% | ▲ +45.04% | $11.53 (+133.03%) |
Mar 12, 2026 32w ago | Press Release | $5.03 $8.23 | ▲ +63.62% | ▲ +52.92% | $11.53 (+129.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers